AU504897B2 - Hydropyrimidines - Google Patents

Hydropyrimidines

Info

Publication number
AU504897B2
AU504897B2 AU18295/76A AU1829576A AU504897B2 AU 504897 B2 AU504897 B2 AU 504897B2 AU 18295/76 A AU18295/76 A AU 18295/76A AU 1829576 A AU1829576 A AU 1829576A AU 504897 B2 AU504897 B2 AU 504897B2
Authority
AU
Australia
Prior art keywords
hydropyrimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU18295/76A
Other languages
English (en)
Other versions
AU1829576A (en
Inventor
T. H. Emmett Jc. Durant G. J. Ganellin C. R Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Publication of AU1829576A publication Critical patent/AU1829576A/en
Application granted granted Critical
Publication of AU504897B2 publication Critical patent/AU504897B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU18295/76A 1975-10-02 1976-09-30 Hydropyrimidines Expired AU504897B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02
GBGB40341/75 1975-10-02

Publications (2)

Publication Number Publication Date
AU1829576A AU1829576A (en) 1978-04-06
AU504897B2 true AU504897B2 (en) 1979-11-01

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18295/76A Expired AU504897B2 (en) 1975-10-02 1976-09-30 Hydropyrimidines

Country Status (36)

Country Link
JP (2) JPS5246087A (en:Method)
AR (1) AR221682A1 (en:Method)
AT (1) AT358045B (en:Method)
AU (1) AU504897B2 (en:Method)
BE (1) BE846452A (en:Method)
BG (1) BG25224A3 (en:Method)
CA (1) CA1067076A (en:Method)
CH (1) CH625801A5 (en:Method)
CS (1) CS203003B2 (en:Method)
DD (1) DD126563A5 (en:Method)
DE (1) DE2643670C2 (en:Method)
DK (1) DK442476A (en:Method)
ES (1) ES452060A1 (en:Method)
FI (1) FI61701C (en:Method)
FR (1) FR2326192A1 (en:Method)
GR (1) GR61307B (en:Method)
HU (1) HU175537B (en:Method)
IE (1) IE44845B1 (en:Method)
IL (1) IL50503A (en:Method)
IN (1) IN146736B (en:Method)
IT (2) IT1070839B (en:Method)
LU (1) LU75922A1 (en:Method)
MW (1) MW3476A1 (en:Method)
MX (1) MX4614E (en:Method)
NL (1) NL7609917A (en:Method)
NO (1) NO145792C (en:Method)
NZ (1) NZ181959A (en:Method)
OA (1) OA05445A (en:Method)
PH (1) PH13921A (en:Method)
PL (1) PL105828B1 (en:Method)
PT (1) PT65590B (en:Method)
RO (1) RO73511A (en:Method)
SE (1) SE431872B (en:Method)
YU (1) YU237276A (en:Method)
ZA (1) ZA765498B (en:Method)
ZM (1) ZM12176A1 (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (en:Method) * 1978-02-13 1983-03-05 Smith Kline French Lab
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
EP0014057B1 (en) 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
CS203003B2 (en) 1981-02-27
AT358045B (de) 1980-08-11
IL50503A0 (en) 1976-11-30
IE44845L (en) 1977-04-02
JPS609755B2 (ja) 1985-03-12
GR61307B (en) 1978-10-19
NO763371L (en:Method) 1977-04-05
OA05445A (fr) 1981-03-31
IE44845B1 (en) 1982-04-21
FI61701B (fi) 1982-05-31
DE2643670A1 (de) 1977-04-14
HU175537B (hu) 1980-08-28
NZ181959A (en) 1978-07-28
ATA711976A (de) 1980-01-15
CA1067076A (en) 1979-11-27
PL105828B1 (pl) 1979-11-30
NO145792C (no) 1982-06-02
MW3476A1 (en) 1977-11-09
IT7830708A0 (it) 1978-12-11
IL50503A (en) 1980-12-31
AR221682A1 (es) 1981-03-13
SE7610409L (sv) 1977-04-03
DE2643670C2 (de) 1982-07-01
FR2326192B1 (en:Method) 1979-01-12
YU237276A (en) 1983-01-21
ZM12176A1 (en) 1977-07-21
MX4614E (es) 1982-07-07
BE846452A (fr) 1977-03-22
DD126563A5 (en:Method) 1977-07-27
FI762803A7 (en:Method) 1977-04-03
IT1070839B (it) 1985-04-02
CH625801A5 (en) 1981-10-15
PT65590B (en) 1978-03-28
RO73511A (ro) 1981-04-30
FI61701C (fi) 1982-09-10
PT65590A (en) 1976-10-01
SE431872B (sv) 1984-03-05
NL7609917A (nl) 1977-04-05
FR2326192A1 (fr) 1977-04-29
BG25224A3 (bg) 1978-08-10
JPS5246087A (en) 1977-04-12
ZA765498B (en) 1977-08-31
JPS5635674B2 (en:Method) 1981-08-19
NO145792B (no) 1982-02-22
LU75922A1 (en:Method) 1977-05-06
IN146736B (en:Method) 1979-08-25
JPS5695186A (en) 1981-08-01
ES452060A1 (es) 1977-10-01
AU1829576A (en) 1978-04-06
DK442476A (da) 1977-04-03
PH13921A (en) 1980-11-04

Similar Documents

Publication Publication Date Title
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU1670276A (en) Tetrahydro-isoquinolines
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU2018176A (en) Pyrazinecarboxamides
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU1829576A (en) Hydropyrimidines
AU1667476A (en) Chroman-4-ones
AU1637076A (en) Banjo-shaped axle-casing
AU1128976A (en) Magneto-alternator
AU1710076A (en) Dihydrooxadiazinones
AU1867676A (en) N-acetylmuramyl-dorl-alanyl-dorl-isoglutamine
AU1722876A (en) Antimacassar
AU1719976A (en) Silacyclo pentenyl-bis-epsilon-caprolactam
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU1520376A (en) Benzocycloheptathiophens
AU1191776A (en) Fluoro-prostaglandins
AU1393076A (en) Dihydromocimycin
AU1804876A (en) 4-hydroxymethyl-2-pyrrolidinones
AU1398876A (en) Aryl-di-thioureas
AU1612176A (en) Fluoro-steroids
AU1625476A (en) Aryltetralins